Replies to post #481226 on Anavex Life Sciences Corp (AVXL)

[Hoskuld]

Hard to argue? It has been argued over and over again. Bottom line: experts supporting Anavex = 58 and experts supporting Investor2014 et al = 0. It is pretty much that simple.

[imho]

"Investor
Hard to argue with those highlighted facts!"

Let me ask you a question. What does the term "both" refer to in Investors highlighted portion referenced below?

"The trial met both its co-primary and key secondary endpoints, showing statistically significant and clinically meaningful improvement in cognition and function as measured by ADAS-Cog, ADCS-ADL, and CDR-SB, respectively."

Read the other parts he showcased carefully.

IMHO